Compare Danaher Corporation (DHR) vs Garmin Ltd. (GRMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Garmin Ltd. — how do they compare? Danaher Corporation trades at $197.72 (market cap $140.88B), while Garmin Ltd. trades at $241.4 (market cap $46.55B). The key difference: Danaher Corporation is far larger — about 3× Garmin Ltd.'s market cap, and Garmin Ltd. pays the higher dividend (1.74%). Which is the better fit depends on your goals.
| DHR | GRMN | |
|---|---|---|
Market Cap | $140.88B | $46.55B |
Sector | Health | Technology |
52-Week High | $242.05 | $267.52 |
52-Week Low | $161.91 | $187.10 |
Enterprise Value | $153.66B | $44.02B |
Dividend Yield | 0.8% | 1.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
Garmin (GRMN) trades at $243.61, up 0.21% on the day, with a bullish technical signal supported by moving averages. The company reported strong revenue growth, reaching $7.25B in 2025, with a net income margin of 23.26%. Recent product launches, including AXIS flight displays and LiveScope 2 sonar, highlight innovation. The stock is near its pivot point of $243, with support at $242 and resistance at $245.
Outlook remains positive with a consensus price target of $282.67, implying 16% upside. Risks include competitive pressures in consumer electronics and aviation markets. Analyst sentiment is mixed, with 74% hold ratings, but earnings beats in recent quarters support growth trajectory. Dividend payments provide shareholder returns, with the next payment scheduled for September 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Garmin Ltd.
Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.
Read more on GRMN →
